Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation ExpenseEBIATLeasesOther Gross PP&E AdjustmentsShares IssuedWages, Salaries and Other
Ratios

Protalix BioTherapeutics (PLX) Shares Issued (2016 - 2025)

Historic Shares Issued for Protalix BioTherapeutics (PLX) over the last 11 years, with Q2 2025 value amounting to $4.0 million.

  • Protalix BioTherapeutics' Shares Issued changed N/A to $4.0 million in Q2 2025 from the same period last year, while for Sep 2025 it was $6.8 million, marking a year-over-year change of. This contributed to the annual value of $3.6 million for FY2024, which is 8486.27% down from last year.
  • Latest data reveals that Protalix BioTherapeutics reported Shares Issued of $4.0 million as of Q2 2025.
  • Protalix BioTherapeutics' Shares Issued's 5-year high stood at $20.0 million during Q1 2023, with a 5-year trough of $1.5 million in Q3 2022.
  • Its 4-year average for Shares Issued is $6.4 million, with a median of $4.0 million in 2023.